Abstract
The 23-year-old Caucasian male propositus presented with symptomatic hypercalcemia, hypophosphatemia and normocalciuria for 2 months. His 29-year-old brother had undergone an operation for recurrent parathyroid adenoma at age 26 and 28. No other member of the family was affected. His father and mother were second-degree relatives. Laboratory studies showed primary hyperparathyroidism (pHPT), while the remaining endocrine studies and genetic testing for multiple endocrine neoplasia 1 and 2A were normal. Technetium-cardiolite scintigraphy and ultrasound scans revealed a parathyroid mass at the left lower neck. Apart from bilateral hearing loss due to gentamicin treatment as a pre-term child, the patient was in of good health. Signs or symptoms of other endocrinopathies were absent. The patient was referred for parathyroidectomy with subsequent autotransplantation of the remaining glands into his sternocleidomastoid muscle. Histological examination revealed an adenoma with oncocytic differentiation, similar to that seen in his brother. The disease may follow a recessive mode of inheritance or may be due to a dominant germ-cell mutation in one of the parents. The presented case may ultimately help in elucidating the molecular genetic basis of this rare form of pHPT.
Similar content being viewed by others
References
Bilezikian J.P. Primary hyperparathyroidsm. In: Favus M.J. (Ed.), Primer on the metabolic bone diseases and disorder of mineral metabolism. Lippincott-Raven, Philadelphia, 1996, p. 181.
Habener J., Arnold A., Potts J T Hyperparathyroidism. In: DeGroot L.J. (Ed.), Endocrinology. W.B. Saunders, Philadelphia, 1995, vol. 2, p. 1044.
Arnold A. Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia. J. Clin. Endocrinol. Metab. 1993, 77: 1108–1112.
Hendy G.N., Arnold A. Molecular basis of PTH overexpression. In: Bilezikian J.P., Raisz L.G., Rodan G.A. (Eds.), Principles of bone biology. Academic Press, San Diego, 1996, p. 757.
Carling T., Correa P., Hessman O., Hedberg J., Skogseid B., Lindberg D., Rastad J., Westin G., Akerstrom G. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 1998, 83: 2960–2963.
Marx S.J., Agarwal S.K., Kester M.B., Heppner C., Kim Y.S., Emmert-Buck M.R., Debelenko L.V., Lubensky I.A., Zhuang Z., Guru S.C., Manickam P., Olufemi S.E., Skarulis M.C., Doppman J.L., Alexander R.H., Liotta L.A., Collins F.S., Chandrasekharappa S.C., Spiegel A.M., Burns A.L. Germline and somatic mutation of the gene for multiple endocrine neoplasia type 1 (MEN1). J. Intern. Med. 1998, 243: 447–453.
Cetani F., Pinchera A., Pardi E., Cianferotti L., Vignali E., Picone A., Miccoli P., Viacava P., Marcocci C. No evidence for mutations in the calcium-sensing receptor gene in sporadic parathyroid adenoma. J. Bone Miner. Res. 1999, 14: 878–882.
Cryns V., Thor A., Xu H., Hu S., Wierman M., Vickery A., Benedict W., Arnold A. Loss of the retinoblastoma tumor suppressor gene in parathyroid carcinoma. N. Engl. J. Med. 1994, 330: 757–761.
Chandrasekharappa S.C., Guru S.C., Manickam P., Olufemi S.E., Collins F.S., Emmert-Buck M.R., Debelenko L.V., Zhuang Z., Lubensky I.A., Liotta L.A., Crabtree J.S., Wang Y., Roe B.A., Weisemann J., Boguski M.S., Agarwal S.K., Kester M.B., Kim Y.S., Heppner C., Dong Q., Spiegel A., Burns A.L., Marx S.J. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 1997, 276: 404–407.
The-European-Consortium-on-MEN1. Identification of the multiple endocrine neoplasia type 1 gene. Hum. Mol. Genet. 1997, 6: 1177–1183.
Mulligan L., Kwok J., Healey C., Elsdon M., Eng C., Gardner E., Love D., Mole S., Moore J., Papi L., Ponder B. Germ-line mutations of the ret proto-oncogene in multiple endocrine neoplasia type 2 A. Nature 1993, 363: 458–460.
Szabo J., Heath B., Hill V., Jackson C., Zarbo R., Mallette L., Chew S., Besser G.M., Thakker R.V., Huff V., Leppert M., Heath H. Hereditary hyperparathyroidism-jaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21–q31. Am. J. Hum. Genet. 1995, 56: 944–950.
Williamson C., Cavaco B.M., Jausch A., Dixon P.H., Forbes S., Harding B., Holtgreve-Grez H., Schoell B., Pereira M.C., Font A.P., Loureiro M.M., Sobrinho L.G., Santos M.A., Thakker R.V. Mapping the gene causing hereditary primary hyperparathyroidism in a Portuguese kindred to chromosome 1q22–q31. J. Bone Miner. Res. 1999, 14: 230–239.
Teh B.T., Farnebo F., Twigg S., Hoog A., Kytola S., Korpi-Hyovalti E., Wong F.K., Nordenstrom J., Grimelius L., Sandelin K., Robinson B., Farnebo L.O., Larsson C. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21–q32 in a subset of families. J. Clin. Endocrinol. Metab. 1998, 83: 2114–2120.
Law W.M. Jr., Hodgson S.F., Heath H.D. Autosomal recessive inheritance of familial hyperparathyroidism. N. Engl. J. Med. 1983, 309: 650–653.
Kassem M., Zhang X., Brask S., Eriksen E.F., Mosekilde L., Kruse T.A. Familial isolated primary hyperparathyroidism. Clin. Endocrinol. (Oxf.) 1994, 41: 415–420.
Wassif W.S., Moniz C.F., Friedman E., Wong S., Weber G., Nordenskjold M., Peters T.J., Larsson C. Familial isolated hyperparathyroidism: a distinct genetic entity with an increased risk of parathyroid cancer. J. Clin. Endocrinol. Metab. 1993, 77: 1485–1489.
Agarwal S.K., Kester M.B., Debelenko L.V., Heppner C., Emmert-Buck M.R., Skarulis M.C., Doppman J.L., Kim Y.S., Lubensky I.A., Zhuang Z., Green J.S., Guru S.C., Manickam P., Olufemi S.E., Liotta L.A., Chandrasekharappa S.C., Collins F.S., Spiegel A.M., Burns A.L., Marx S.J. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum. Mol. Genet. 1997, 6: 1169–1175.
Heath-III H. The familial benign hypocalciuric hypercalcemia syndrome. In: Bilezikian J.P., Raisz L.G., Rodan G.A. (Eds.), Principles of bone biology. Academic Press, San Diego, 1996, p. 769.
Mayr B., Apenberg S., Rothamel T., von zur Muhlen A., Brabant G. Menin mutations in patients with multiple endocrine neoplasia type 1. Eur. J. Endocrinol. 1997, 137: 684–687.
Mayr B., Potter E., Goretzki P., Ruschoff J., Dietmaier W., Hoang-Vu C., Dralle H., Brabant G. Expression of Ret/PTC1, -2, -3, -delta3 and -4 in German papillary thyroid carcinoma. Br. J. Cancer 1998, 77: 903–906.
Marx S.J. Familial hypocalciuric hypercalcemia. In: Favus M.J. (Ed.), Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott-Raven, Philadelphia, 1996, p. 190.
Barry M.K., van Heerden J.A., Grant C.S., Thompson G.B., Khosla S. Is familial hyperparathyroidism a unique disease? Surgery 1997, 122: 1028–1033.
Heath-III H., Hobbs M.R. Familial hyperparathyroid syndromes. In: Favus M.J. (Ed.), Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott-Raven, Philadelphia, 1996, p. 187.
Thakker R.V. Multiple endocrine neoplasia type 1. In: DeGroot L.J. (Ed.), Endocrinology. Saunders, Philadelphia, 1995, vol. 3, p. 2815.
Gagel R.F. Multiple endocrine neoplasia type 2. In: DeGroot L.J. (Ed.), Endocrinology. Saunders, Philadelphia, 1995, vol. 3, p. 2832.
Online Mendelian Inheritance in Man. Multiple endocrine neoplasia type I, mime number #131100. Johns Hopkins University, Baltimore, MD, 1999, http://www.ncbi.nlm.nih.gov/
Online Mendelian Inheritance in Man. Multiple endocrine neoplasia type II, mime number #171400. Johns Hopkins University, Baltimore, MD., 1999, http://www.ncbi.nlm. nih.gov/omim/
Pollak M.R., Brown E.M., WuChou Y.H., Hebert S.C., Marx S.J., Steinmann B., Levi T., Seidman C.E., Seidman J.G. Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993, 75: 1297–1303.
Edwards B.D., Patton M.A., Dilly S.A., Eastwood J.B. A new syndrome of autosomal recessive nephropathy, deafness, and hyperparathyroidism. J. Med. Genet. 1989, 26: 289–293.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bergwitz, C., Bremer, B., Soudah, B. et al. Familial isolated parathyroid adenoma in a consanguineous family. J Endocrinol Invest 24, 349–355 (2001). https://doi.org/10.1007/BF03343872
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343872